Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00332436
Status:
COMPLETED
Last Update Posted:
2011-05-30
First Post:
2006-05-30
Brief Title:
Safety and Efficacy Study of BrimonidineTimolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Sponsor:
Allergan
Organization:
Allergan
Organization Data
Organization:
Allergan
Class:
INDUSTRY
Study ID:
190342-013T
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Allergan
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Therapeutic Area Head
Old Organization:
Allergan Inc